Macababayao, Ethan G.

HRN: 23-82-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2023
CEFTRIAXONE 1G (VIAL)
09/30/2023
10/07/2023
IV DRIP
1g
Q24
PCAP C
Waiting Final Action 
09/30/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
09/30/2023
10/07/2023
ORAL
3ml
Bid
PCAP C
Waiting Final Action 
09/30/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/30/2023
10/16/2023
IV DRIP
863mg
Q6
Sepsis, Pcap
Waiting Final Action 
09/30/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/30/2023
10/06/2023
IV
115mg
Q8
Sepsis
Waiting Final Action 
10/10/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/10/2023
10/16/2023
IV
170mg
OD
Sepsis
Waiting Final Action 
10/10/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/10/2023
10/17/2023
IV
100mg
Q6hours
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: